NCT00003677 2018-10-25
Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
7 trialsNCT00003693 2018-10-25
Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00003557 2014-03-06
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
University of Chicago
Phase 2 Completed
NCT00005579 2013-06-26
Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003626 2013-04-05
Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00003778 2013-02-08
Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003914 2011-05-11
Dolastatin 10 in Treating Patients With Advanced Kidney Cancer
Mayo Clinic
Phase 2 Completed